First isolation of Acinetobacter johnsonii co-producing PER-2 and OXA-58 β-lactamases

Diagn Microbiol Infect Dis. 2014 Dec;80(4):341-2. doi: 10.1016/j.diagmicrobio.2014.09.013. Epub 2014 Sep 22.

Authors

Carlos Hernan Rodríguez¹, Marcela Nastro², Laura Dabos², Claudia Barberis², Carlos Vay², Angela Famiglietti²

Affiliations

¹ Laboratorio de Bacteriología, Departamento de Bioquímica Clínica, Hospital de Clínicas José de San Martín, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina. Electronic address: carlos_hernanrodriguez@hotmail.com.
² Laboratorio de Bacteriología, Departamento de Bioquímica Clínica, Hospital de Clínicas José de San Martín, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Buenos Aires, Argentina.

PMID: 25294301
DOI: 10.1016/j.diagmicrobio.2014.09.013

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Acinetobacter / drug effects*
Acinetobacter / genetics
Acinetobacter / isolation & purification*
Acinetobacter / metabolism*
Acinetobacter Infections / drug therapy
Acinetobacter Infections / microbiology*
Anti-Bacterial Agents / therapeutic use
Drug Resistance, Bacterial / drug effects
Female
Humans
Microbial Sensitivity Tests
Middle Aged
Vancomycin / therapeutic use
beta-Lactamases / metabolism*

Substances

Anti-Bacterial Agents
Vancomycin
beta-Lactamases
beta-lactamase OXA-58, Acinetobacter baumannii